# Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma

> **NCT00669071** · PHASE4 · TERMINATED · sponsor: **Galderma R&D** · enrollment: 56 (actual)

## Conditions studied

- Melasma

## Interventions

- **DRUG:** Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%
- **DRUG:** Cetaphil® Moisturizing Cream as Inactive Control

## Key facts

- **NCT ID:** NCT00669071
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** Enrollment closed
- **Last updated:** 2022-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00669071

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00669071, "Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00669071. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*